SCHEMBL7225445

SCHEMBL7225445

CC(=O)ON=C(C)N(CCCC[C@H](N)C(=O)O)OC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 9/20 0.46
NOS1 P29475 8/20 0.46
NOS3 P29474 5/20 0.46
CYP1A2 P05177 2/20 0.46
TSHR P16473 2/20 0.46
CYP3A4 P08684 1/20 0.46
BLM P54132 1/20 0.44
CYP2C19 P33261 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
DDAH1 O94760 5/20 0.40
GSR P00390 1/20 0.39
GLA P06280 1/20 0.39
NFKB1 P19838 1/20 0.39
APEX1 P27695 1/20 0.39
THPO P40225 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7225440 1.00 NOS2 (0.46) NOS2NOS1NOS3CYP1A2TSHR
Hydrochloric Acid SCHEMBL8202178 0.99 NOS2 (0.47) NOS2NOS1NOS3CYP1A2TSHR
Hydrochloric Acid SCHEMBL8202182 0.99 NOS2 (0.47) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL8200560 0.84 NOS2 (0.43) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7909659 0.84 NOS2 (0.43) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7909780 0.82 NOS2 (0.42) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7909776 0.82 NOS2 (0.42) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7225600 0.82 NOS2 (0.43) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7225602 0.82 NOS2 (0.43) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7220222 0.80 NOS2 (0.49) NOS2NOS1NOS3CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207708-B1 FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, G. D. SEARLE & COMPANY 2001-03-27 US claimed
EP-0885188-B1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2000-09-27 EP claimed
EP-0885188-A1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1998-12-23 EP claimed
WO-1997032844-A9 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS 1997-12-24 WO claimed
WO-1997032844-A1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1997-09-12 WO claimed
US-6576780-B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors GD SEARLE & COMPANY 2003-06-10 US disclosed
US-6207708-B1 FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, G. D. SEARLE & COMPANY 2001-03-27 US disclosed
EP-0885188-B1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2000-09-27 EP disclosed
US-5981511-A AN ENZYME INHIBITOR FOR REDUCING NITRIC OXIDE, TREATING HYPOTENSION SUCH AS TOXIC SHOCK AND THERAPY WITH CERTAIN CYTOKINES G.D. SEARLE & CO. (US) 1999-11-09 US disclosed
EP-0885188-A1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1998-12-23 EP disclosed
WO-1997032844-A9 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS 1997-12-24 WO disclosed
WO-1997032844-A1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1997-09-12 WO disclosed